CL2A, CAS 2616704-22-2

Product Description: CL2A is a claevable complicated PEG8- and triazole-containing PABC-peptide-mc linker. CL2A is cleavable through pH sensitivity, giving rise to bystander effect, and binds the antibody at a cysteine residue via a disulfide bond. Labetuzumab govitecan used this linker[1].

Applications: COVID-19-immunoregulation

Formula: C50H79N9O16

References: [1]Samantha Congreve, et al. Antibody drug conjugates (ADC). Teknisk- naturvetenskaplig fakultet

CAS Number: 2616704-22-2

Molecular Weight: 1062.21

Compound Purity: 98.17

Research Area: Cancer; Inflammation/Immunology

Solubility: DMSO : 200 mg/mL (ultrasonic)

Target: ADC Linker

• SKU: MEXHY-128945-5
• Manufacturer: MedChemExpress
• Manufacturer SKU: HY-128945-5
• Green Labware: No
• Package Unit: 5 mg
• Quantity Unit: STK